#1Lithium 6.941 Livent and Allkem to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023 Livent Allkem#2Today's Presenters CREAM Paul Graves President & CEO, Livent Martín Pérez de Solay Managing Director & CEO, Allkem 2#3Transaction Details Overview Governance Structure Closing All-stock merger of equals ■ Allkem shareholders to receive right to one share of a new public holding company ("NewCo") for each existing Allkem share¹, and Livent shareholders to receive 2.406 shares of New Co for each existing Livent share ▪ Post transaction NewCo ownership split2: -56% Allkem shareholders / ~44% Livent shareholders ■ Exchange ratio reflective of contribution to risk-adjusted NAV, with expected synergies driving material NAV accretion to Allkem and Livent shareholders Implied combined global market capitalization of $10.6Bn³ before synergies Peter Coleman to be Chairman ■ Paul Graves to be CEO and Director, and Gilberto Antoniazzi to be CFO ▪ New Co Board to have 14 members, consisting of 7 directors designated by Livent and 7 directors designated by Allkem ■ Commercial, operations, and capital deployment teams to be represented from both companies ■ ▪ New Co corporate headquarters to be in North America, with exact location as well as company name to be announced at a later date ■ Primary listing on NYSE; foreign exempt listing on ASX via Chess Depository Interests ("CDIs") ■ Seeking inclusion in key US indices and S&P/ASX 200 index New Co incorporated in the Bailiwick of Jersey with corporate residency in Ireland ■ Transaction is expected to close by end of calendar year 2023 ■ Closing is subject to regulatory approvals and other customary conditions, including shareholder approval for each company, Independent Expert opinion, tax opinion delivery, Australian tax class ruling confirmation, and Australian court approval Notes: 1. Allkem shareholders to receive one NewCo ASX-listed CDI for each Allkem share held (with the ability to elect to receive NewCo NYSE-listed shares instead of CDIs), except for shareholders in certain ineligible jurisdictions who will receive cash proceeds from the sale of NewCo CDIs in lieu of such CDIs 2. Ownership based on fully diluted shares outstanding (including Livent's convertible note) 3. Based on market data as at close of trading on May 9, 2023; reflects un-synergized values 3#4A Lithium Chemicals Leader Livent Allkem Business-Critical Scale Value-Adding Vertical Integration Accelerated Growth Immediate increase in operating and commercial scale ✓ Faster and lower risk growth Expected significant, tangible synergies ✓ Broad and reliable Americas-based product offering Best-in-class ESG practices#5Compelling Transaction Logic ✓ Combination unlocks expected ~$125MM annual run-rate synergies and ~$200MM one-time capex savings 8 Business-Critical Scale ✓ A leading global lithium chemicals producer ✓ Presence in all three major lithium geographies¹ ✓ Combined lithium deposit base amongst the largest in the world OIOIO ↑ Value-Adding Vertical Integration ✓ Combined exposure to the broadest range of lithium chemical products ✓ Low-cost assets and more resilient supply chain to better serve customers ✓ Enhanced operating flexibility and efficiency Notes: 1. Geographies include the South America Lithium Triangle, Western Australia, and Canada 2. See endnote 1 for further detail on combined Allkem and Livent CY'27E attributable lithium production capacity Accelerated Growth ✓ Strong pipeline of advanced projects ✓ Highly complementary assets and business models enable acceleration and de-risking of growth projects ✓ Estimated ~250ktpa of LCE production capacity by CY'27E² ✓ Leading ESG profile with an unwavering commitment to sustainability and responsible growth 5#6Business-Critical Scale A New Large Cap Lithium Chemicals Company Strengthened Balance Sheet and Financial Flexibility to Deliver Growth Livent + Global Market Capitalization ¹ $10.6Bn Value-Adding Vertical Integration CY'22A Adj. EBITDA² $1.2Bn Combined Key Statistics Allkem CY'22A Revenue² $1.9Bn Liquidity ³ $1.4Bn Accelerated Growth ✓ EBITDA and cash flow to benefit from expected synergies and significant volume growth Notes: 1. Implied combined market capitalization as at close of trading on May 9, 2023, pre-synergies 2. See endnote 2 for further detail on combined Allkem and Livent financial data; combined financials are pre-synergies 3. Includes Allkem's available cash as of March 31, 2023, and Livent's cash & equivalents and available funds under revolving credit facilities as of March 31, 2023; see endnote 2 for further detail on combined Allkem and Livent financial data 6#7Business-Critical Scale Leading Global Integrated Production Profile Diversified Product Offering With Exposure to Lithium Performance Chemicals Product Exposure Spodumene Carbonate Hydroxide Specialties 343 Albemarle Forecast Attributable Lithium Production Capacity¹ (ktpa LCE) 302 SQM Value-Adding Vertical Integration 248 New Co (Combined) 229 Ganfeng 163 Allkem Standalone 141 Pilbara Minerals 122 Lithium Americas 110 Mineral Resources Accelerated Growth 100 Tianqi Notes: 1. Shown on a net attributable basis; see endnote 1 for further detail on combined Allkem and Livent CY'27E attributable lithium production capacity and endnote 3 for further detail on forecast attributable lithium production capacity. 85 Livent Standalone 7#8Business-Critical Scale Hard Rock Brine Chemical Processing Diversified Across Key Lithium Geographies and Products Leading Presence in Key Lithium Regions James Bay Nemaska (50%) Bessemer City Ar Cauchari Hombre Muerto Value-Adding Vertical Integration Bécancour (50%) 4. Remaining ownership split between Toyota Tsusho (25.0%) and JEMSE (8.5%) 5. Toyota Tsusho owns remaining 25.0% economic interest Olaroz (66.5%)4 Sal de Vida Güemes Bromborough, England 2. Lithium specialties includes butyllithium, high purity lithium metal, lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics 3. Includes minimal lithium chloride sales in CY'22A CY'22A Combined Revenue by Product¹ Lithium Specialties 17% Lithium Hydroxide 22% Accelerated Growth 2 Notes: For assets not 100% owned by either Livent or Allkem, corresponding ownership stake is indicated in parenthesis. Livent offices in Seoul (South Korea), Tokyo (Japan), Shanghai (China), and Charlotte (North Carolina) not shown 1. See endnote 2 for further detail on combined Allkem and Livent financial data; breakdown excludes tantalum sales which were minimal in CY'22A Spodumene 31% Naraha (75%) 5 Mt. Cattlin Lithium Carbonate 31% Rugao, China Zhejiang, China Zhangjiagang, China 3 8#9Brine Highly Complementary Business Model Hard Rock Business-Critical Scale Chemical Processing H Argentine Brine Australia Hard-Rock Nemaska Value-Adding Vertical Integration Bromborough, UK BuLi Livent Hombre Muerto LiCa¹ Güemes LIC1² Nemaska (50%) Spod Bécancour (50%) LIOH Bessemer City (US) LIOH, Li Metal, Other Notes: For assets not 100% owned by either Livent or Allkem, corresponding ownership stake is indicated in parenthesis 1. Lithium carbonate ("Lica") 2. Lithium chloride ("LICI") Sal de Vida LiCa¹ Integrated China LIOH, BuLi Allkem Cauchari LiCa ¹ Mt Cattlin (Australia) Spod James Bay Spod Québec Processing LiOH Naraha (Japan) (75%) LiOH Accelerated Growth Olaroz (66.5%) LiCa¹ Integrated Québec Performance Chemicals 9